Samir Kaul - 14 Jun 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role: Director
Signature: /s/ John J. Demeter, as attorney-in-fact for Samir Kaul
Issuer symbol: GH
Transactions as of: 14 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 16 Jun 2023, 18:08:44 UTC
Previous filing: 24 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GH	COMMON STOCK	Options Exercise	$0	+5,531	+94%	$0.000000	11,404	14 Jun 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GH	RESTRICTED STOCK UNITS	Options Exercise	$0	-5,531	-100%	$0.000000^*	0	14 Jun 2023	COMMON STOCK	5,531	$0.000000	Direct	F1, F2
transaction	GH	STOCK OPTION (RIGHT TO BUY)	Award	$0	+8,803		$0.000000	8,803	14 Jun 2023	COMMON STOCK	8,803	$38.00	Direct	F3
transaction	GH	RESTRICTED STOCK UNITS	Award	$0	+5,592		$0.000000	5,592	14 Jun 2023	COMMON STOCK	5,592	$0.000000	Direct	F2, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restricted stock units vest in full on the one-year anniversary of the grant date, June 15, 2022 or the date of the next year annual stockholders meeting, whichever is earlier.
F2	Not applicable for Restricted Stock Units.
F3	The stock option vests in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier.
F4	The restricted stock units vest in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier.